GlassScriptPhysician profile
Paul Luong
NPI 1992155923
$44,122.89
in general payments reported to CMS, 2019-2025
10 companies · $5,721 in 2025
The $5,721 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $6,285 · 2021: $3,486 · 2022: $3,800 · 2023: $14K · 2024: $11K · 2025: $5,721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $21K · Travel and Lodging: $4,963 · Food and Beverage: $2,807 · Consulting Fee: $1,500 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $20,650.00 |
| Travel and Lodging | $4,963.08 |
| Food and Beverage | $2,807.09 |
| Consulting Fee | $1,500.00 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $33,109.14 | 2022-2025 | Infuse, Infuse Multifocal |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $9,784.87 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $746.28 | 2019-2025 | Acuvue |
| Coopervision INC. | $206.98 | 2019-2023 | Myday Contact Lens |
| Abb Con-Cise Optical Group LLC | $107.86 | 2022-2023 | Contact Lens, Spectacle Lenses |
| Allergan, INC. | $71.69 | 2020 | |
| Sun Pharmaceutical Industries INC. | $34.45 | 2021 | |
| Rxsight INC | $25.59 | 2024 | Rxsight Injector Handpiece, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Glaukos Corporation | $23.89 | 2024 | Radius |
| Alcon Vision LLC | $12.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Luong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.